Pharmaceutical Commerce - October 2024 Issue (PDF)

How practical is this form of pricing in the pharma setting?

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

A cross-sectional study uncovers the current and projected economic burden of Alzheimer’s disease and related dementias (ADRD) through 2060 among non-Latino African American, Latino, and non-Latino White adults.